What To Do If You Have Colon Cancer
One of the many aggressive and destructive forms of cancer is neuroendocrine carcinoma of colon. The worst part of this disease is that more often t...
One of the many aggressive and destructive forms of cancer is neuroendocrine carcinoma of colon. The worst part of this disease is that more often than not it is detected at the advanced stages where is it very difficult to do anything about it.
As the effects of neuroendocrine colon cancer become visible only in the most advanced stages the rate of survival of the patient diminishes. The polyps or tumours of the colon are mostly detected with distant metastases. Most recent surveys show that reports reveal that most of the cases of neuroendocrine cancer ends in death.
Though the possibilities of neuroendocrine carcinoma in colon are very rare, if one has the misfortune to become affected the patient’s heath appears even worse than patients suffering from adenocarcinoma.
Researchers have showcased that the end results of this form of cancer do not differ with age, sex or tumour location. However, neuroendocrine colon carcinoma will depend heavily on the tumour’s stage. The usual trends have revealed that people in stage 1 and 2 of cancer usually do not suffer from neuroendocrine colon cancer. But alternately in several cases, when the tumour is in stage 3 or 4, it is a laborious and hard task the neuroendocrine colon carcinoma.
It is unfortunate that medical science has developed no adequate methods to deal with this particular cancer. One of the most popular methods that the doctors often use is immunohistochemical staining methods. this method assists the doctors to detect the severity of the neuroendocrine colon cancer and assists doctors in deciding on the most helpful medication and a way to treat it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. Involved in that, is the staining of the tumour with a monoclonal antibody A-80 which helps to identify the quantum of neuroendocrine differentiation and nature of the damage on the patient’s health.
Neuroendocrine colon carcinoma is difficult to treat and in a case study where several patients suffered from this disease were examined, an observation was made that the average survival rate surrounding this disease was only about seven months. While in a predominant stage, the rates were as less as five months. The great majority of these cases were initially detected as carcinoids but they soon became in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer does not have a good prognosis and surgery is not always a successful treatment so surgery may not even cure the patient. So this makes it important to notice the presence of this disease on time and administer the proper treatment.
You can visit: and for more information.